Revolution Medicines Inc (RVMD) Company Profile & Statistics

Revolution Medicines Inc
RVMD
(Nasdaq - US)
N/A
40.20
+1.01 (+2.58%)
in:usd•As of: May 03, 2024 15:59 UTC -4
Open
40.00
High
40.21
Low
39.11

About Revolution Medicines Inc

CEO

Mark A. Goldsmith

Headquarters

700 saginaw drive

redwood city, ca 94063, united states

Auditor

PricewaterhouseCoopers LLP

Employees

378

Share Holders

100

Website

www.revmed.com

Industry

pharmaceuticals other

Sector

health technology

Company Overview

Revolution Medicines Inc. is a clinical-stage oncology company. It is focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways. Revolution Medicines Inc. is based in CA, United States.

Revolution Medicines Inc Statistics

Valuation Measures

Market Capitalization ²	6.85B
Enterprise Value	6.16B
Enterprise Value/EBITDA (ttm)	-12.31
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	3.50
Price to Sales (ttm)	224.17
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	75.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-6327.98%
Return on Equity (ttm)	-38.39%
Return on Invested Capital (ttm)	-39.51%
Return on Assets (ttm)	-33.61%

Income Statement

Revenue (ttm)	11.58M
Revenue Per Share (ttm)	0.07
Gross Profit (ttm)	11.58M
EBITDA (ttm)³	-500.08M
Net Income Avi to Common (ttm)	-436.37M
Diluted EPS (ttm)	-3.77

Share Statistics

Beta (5Y Monthly)	1.46
52-Week Change	68.69%
S&P500 52-Week Change	26.43%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	164.69M
Dividend Yield	0.00%
Float ⁴	156.00M
% Held by Insiders	8.50%
% Held by Institutions	94.34%

Balance Sheet

Total Cash (mrq)	1.85B
Total Cash Per Share (mrq)	11.25
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	13.06%
Quick Ratio (mrq)	13.06%
Book Value Per Share (mrq)	11.09

Cash Flow

Operating Cash Flow Per Share (ytd)	-3.10
Free Cash Flow (ytd)	-358.30M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Revolution Medicines Inc

Trade With A Regulated Broker